| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 754.80M | 848.20M | 1.01B | 1.07B | 686.60M |
| Gross Profit | 101.80M | 754.60M | 873.20M | 126.22M | 91.27M |
| EBITDA | 21.70M | -232.30M | 94.00M | -54.10M | 14.09M |
| Net Income | -24.80M | -306.90M | -6.00M | -160.50M | -56.72M |
Balance Sheet | |||||
| Total Assets | 1.35B | 1.45B | 1.72B | 1.94B | 1.69B |
| Cash, Cash Equivalents and Short-Term Investments | 240.80M | 168.40M | 145.70M | 223.57M | 301.02M |
| Total Debt | 355.80M | 349.90M | 370.10M | 385.30M | 353.06M |
| Total Liabilities | 841.60M | 867.80M | 854.00M | 1.09B | 884.43M |
| Stockholders Equity | 505.90M | 577.40M | 865.80M | 849.51M | 801.14M |
Cash Flow | |||||
| Free Cash Flow | 100.40M | 53.10M | -16.60M | 46.20M | 34.52M |
| Operating Cash Flow | 102.70M | 57.10M | -10.70M | 64.10M | 49.09M |
| Investing Cash Flow | -5.20M | -12.30M | -13.30M | -139.79M | -106.62M |
| Financing Cash Flow | -19.80M | -44.50M | -43.00M | -32.40M | 208.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | £241.46M | -49.08 | 9.17% | 4.98% | -5.98% | -74.21% | |
62 Neutral | £79.06M | 4.75 | 6.44% | 4.25% | -0.49% | -9.92% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | £270.18M | -13.78 | -4.92% | 6.33% | -11.01% | 92.56% | |
55 Neutral | £160.23M | -7.44 | -6.04% | 1.09% | -12.14% | -117.78% | |
49 Neutral | £2.87B | -3.51 | -7.54% | 9.68% | -8.08% | -139.61% | |
45 Neutral | £15.49M | -1.11 | -37.24% | ― | -4.43% | -279.70% |